Topics
Innovation
Laser
Medical
Practice
Research
Surgical
Training
View Issue
In This Issue
Steven D. Vold, MD
Melissa (Wen-Jeng) Yao, MD, and Jeffrey S. Schultz, MD
Christopher A. Girkin, MD
Practical research may lead to the better care of patients with glaucoma.
Albert S. Khouri, MD, and Tony Realini, MD, MPH
Jess T. Whitson, MD
Anurag Shrivastava, MD
Technology can help us to communicate with primary health providers to coordinate care.
George Shafranov, MD
These steps are imperative to accurate diagnosis and treatment.
Yara P. Catoira-Boyle, MD
This technology enhances physicians' ability to diagnose disease and its progression, but clinical acumen is still essential.
Ian Conner, MD, PhD, and Joel S. Schuman, MD
Recently released preservative-free agents will create a new paradigm for the treatment of glaucoma.
Lawrence M. Hurvitz, MD
The answer is highly variable and influenced by commercial considerations, the patient, and the physician.
Nicholas P. Bell, MD
Optimizing patients' outcomes.
Henry D. Jampel, MD, MHS
This proven and effective treatment modality is a powerful option for initial IOP lowering in the newly diagnosed glaucomatous or ocular hypertensive patient.
Ahmad A. Aref, MD
The procedure is still viable.
Richard A. Lehrer, MD
Technical pearls and advice on selecting a device for tube shunt surgery.
Boris Dilman, MD, and Anjali S. Hawkins, MD, PhD
Stratifying the disease may improve communication between physicians and their patients and educate payors.
Ronald L. Fellman, MD
Nathan M. Radcliffe, MD
Dr. Singh predicts how microinvasive glaucoma surgery will affect ophthalmologists' treatment of the disease and describes one of his star-studded evenings.
Subscribe
Stay up to date all on all things Glaucoma by signing up to receive our print publication or subscribe to our email alerts.